U.S. Markets closed

Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $2.6 million of Shares

- By insider

CEO of Odonate Therapeutics Inc (ODT) Kevin C Tang bought 140,000 shares of ODT on 03/08/2019 at an average price of $18.26 a share. The total cost of this purchase was $2.6 million.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. It is developing tesetaxel an chemotherapy agent used in the treatment of cancer. Odonate Therapeutics Inc has a market cap of $517.410 million; its shares were traded at around $19.34 .


CEO Recent Trades:

  • CEO, 10% Owner Kevin C Tang bought 140,000 shares of ODT stock on 03/08/2019 at the average price of $18.26. The price of the stock has increased by 5.91% since.

Directors and Officers Recent Trades:

  • Director Jeff L Vacirca bought 3,000 shares of ODT stock on 03/04/2019 at the average price of $17. The price of the stock has increased by 13.76% since.

For the complete insider trading history of ODT, click here

.This article first appeared on GuruFocus.